论文部分内容阅读
干细胞移植应用于心肌缺血的临床研究为各种原因引起的缺血性心脏病患者带来了新的希望。虽然目前的研究结果还有待大规模、随机、双盲、对照研究的验证,但学者们在干细胞的纯化鉴定、细胞移植路径及移植时机等方面的不断探索,将逐步为细胞移植治疗在临床的广泛应用扫清障碍,使细胞移植成为治疗缺血性心脏病的有效方法之一。
The clinical application of stem cell transplantation in myocardial ischemia has brought new hope for patients with ischemic heart disease caused by various reasons. Although the current research results still need to be verified by large-scale, randomized, double-blind, and controlled studies, scholars’ continuous exploration in stem cell purification and identification, cell transplantation pathways and transplantation opportunities will gradually lead to the clinical application of cell transplantation in clinical Extensive use of clear obstacles to cell transplantation as an effective method of treatment of ischemic heart disease.